Novonesis (Novozymes A/S) (NVZMY)
57.83
+0.11
(+0.19%)
USD |
OTCM |
May 19, 15:59
Novonesis (Novozymes A/S) Market Cap : 26.96B for May 19, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| RPM International, Inc. | 12.13B |
| Givaudan SA | 32.38B |
| Symrise AG | 12.31B |
| DSM-Firmenich AG | 19.78B |
| Arq, Inc. | 109.03M |
Market Cap Related Metrics
| PE Ratio | 39.07 |
| PS Ratio | 5.560 |
| PEG Ratio | 0.9739 |
| Price to Book Value | 2.422 |
| Price to Free Cash Flow | 30.65 |
| Price | 57.83 |
| Earnings Yield | 2.56% |
| PEGY Ratio | 0.9334 |
| Operating PE Ratio | 27.16 |
| Normalized PE Ratio | 36.44 |